Cargando…
Rapamycin for longevity: opinion article
From the dawn of civilization, humanity has dreamed of immortality. So why didn’t the discovery of the anti-aging properties of mTOR inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinica...
Autor principal: | Blagosklonny, Mikhail V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814615/ https://www.ncbi.nlm.nih.gov/pubmed/31586989 http://dx.doi.org/10.18632/aging.102355 |
Ejemplares similares
-
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
por: Blagosklonny, Mikhail V.
Publicado: (2023) -
Rapamycin, proliferation and geroconversion to senescence
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023) -
Progeria, rapamycin and normal aging: recent breakthrough
por: Blagosklonny, Mikhail V.
Publicado: (2011) -
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
por: Blagosklonny, Mikhail V.
Publicado: (2012)